10 Tips For Selecting High-Performing Clinical Sites

Investigative sites are crucial to clinical trials, ensuring the efficacy and safety of new drugs. For this reason, effective site selection is pivotal, as clinical trials are lengthy, expensive, and often experience delays. Research estimates it costs over $2 billion to bring a new drug to market, with daily revenue losses due to delays ranging from $1M to $8M.

Despite the high stakes, site selection remains manual and error-prone, leading to poor enrollment and increased costs. Studies show 37% of sites under-enroll and 11% fail to enroll any subjects, causing delays and budget overruns. To mitigate these issues, sponsors often engage more sites than necessary, eroding trust and transparency. By doing this, sponsors can better compare site infrastructure, staff experience, past performance, disease focus, and patient proximity, among other factors.

Learn more about how a strategic approach to site selection can enhance resource productivity, reduce costs, and improve the success of clinical trials be reading the article below.